About Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research

Pioneering pharmaceutical research to improve healthcare outcomes across Lebanon and the Middle East.

Guided by Purpose, Driven by Excellence.

Vision & Mission
Vision

To establish Lebanon as a regional hub for pharmaceutical research and innovation, ensuring that patients across the Middle East have access to safe, effective, and affordable medications.

Mission

To conduct high-quality bioequivalence studies that meet international regulatory standards. By fostering collaboration between academia, the pharmaceutical industry, and regulatory authorities, we aim to build confidence in generic medications and contribute to improved healthcare outcomes in Lebanon and beyond.

Part of the LAU Legacy

Clinical and data analysis services are supported by LAU's reputable School of Medicine, School of Pharmacy, School of Nursing, and the LAU Medical Centers (LAU Medical Center-Rizk Hospital and LAU Medical Center-Saint John's Hospital).

A scientist handling lab equipment inside a laboratory, with a test tube rack in hand and a small centrifuge machine in the background.
A female scientist in a white lab coat and blue gloves conducting experiments with test tubes in a laboratory.
A scientist wearing blue gloves using a tweezer to place a sample into a petri dish inside a laboratory. The petri dish is on a digital balance or scale.

The Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research operates within a dynamic ecosystem for research, innovation, and industry collaboration. Clinical and data analysis services are supported by LAU's reputable School of Medicine, School of Pharmacy, School of Nursing, and the LAU Medical Centers (LAU Medical Center-Rizk Hospital and LAU Medical Center-Saint John's Hospital).

State-of-the-Art Facility

Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research facility spans approximately 1,350 square meters across two dedicated floors, purpose-built for pharmaceutical research to the highest international standards.

BioAnalytical Laboratory

Equipped with advanced LC-MS/MS instruments for method development, validation, and sample analysis. Our laboratory follows ICH M10 guidelines for bioanalytical method validation, ensuring data integrity and regulatory compliance.

Clinical Unit

A 42-bed clinical facility designed to accommodate volunteer subjects for bioequivalence studies. The unit includes dedicated spaces for subject monitoring, blood sampling, sample processing, and medical oversight, all compliant with ICH E6 (R2) guidelines for Good Clinical Practice.

Close-up of several test tubes filled with blue liquid in a laboratory setting, with a microscope and blurred scientific equipment in the background.
0
BioAnalytical Laboratory
0
Clinical Unit

Leadership

  • A man with glasses and a bald head smiling, wearing a suit and tie, standing in front of a bookshelf with books and a framed picture in the background.

    Dr. Moise Khayrallah



    On February 27, 2026, Dr. Moise Khayrallah signed a landmark gift agreement with LAU, establishing the endowed fund that supports the center bearing his name, advancing pharmaceutical and medical research for generations to come.

  • A middle-aged man with gray hair in a navy blue suit, white shirt, and yellow patterned tie, smiling in an indoor setting with windows in the background.

    Dr. Chaouki T. Abdallah

    President

    Chaouki T. Abdallah became the tenth president of LAU on October 1, 2024.

  • Professional woman with long brown hair, wearing a black blazer and a colorful silk scarf, smiling in an indoor setting.

    Dr. Zeina Khouri-Stevens

    Executive Vice President

    Dr. Zeina Khouri-Stevens was appointed Executive Vice President for Health Services on July 1, 2025, tasked with strengthening and unifying LAU’s academic health system.

  • Close-up portrait of a middle-aged man with light skin, light-colored eyes, and short, slightly receding brown hair. He is smiling and wearing a striped shirt.

    Sam H. Haidar, Ph.D., R.Ph.

    Executive Director

    Dr. Haidar is the Executive Director of the Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research. Prior to this appointment, Dr. Haidar served 27 years in different roles within the US FDA, Center for Drug Evaluation and Research

Oversight and Strategy Board

  • Dr. Moise Khayrallah

    Donor Representative (Chair)

  • Dr. Zeina Khouri-Stevens

    EVP Health Affairs (Vice-Chair)

  • Dr. Elie Badr

    VP Business Development and Global Affairs

  • Mrs. Carole Abi Karam

    Pharma/CRO Executive

  • Dr. Rita Karam

    Regulatory Affairs/Quality Expert

  • Dr. Hady Ghanem

    Biomedical/Clinical Research Expert

  • Dr. Joseph Stephan

    Legal/Bioethics Expert

  • Dr. Sam Haidar

    Khayrallah Center Director

  • Dr. Naser Alsharif

    Dean of Pharmacy

  • Dr. Sola Aoun Bahous

    Dean of Medicine

  • Dr. Costantine Daher

    Dean of Nursing

  • VP Rasha Fadda

  • Mr. Mario Rebeiz

    LAU Finance/Grants Representatives